Related Experiment Video

Updated: Aug 11, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Treatment of hyperlipidemia in women

J M Walsh1, D Grady

  • 1Department of Medicine, University of California San Francisco/Mount Zion 94115, USA.

JAMA
|October 11, 1995
PubMed

Insights

Lipid lowering shows no benefit for total mortality in healthy women but may reduce coronary heart disease (CHD) mortality in women with existing coronary disease. Further research is needed for high-risk women.

Area of Science:

  • Cardiovascular Medicine
  • Preventive Cardiology
  • Lipid Metabolism

Background:

  • Coronary heart disease (CHD) is a significant health concern for women.
  • The role of lipid lowering in preventing CHD events in women requires comprehensive assessment.

Purpose of the Study:

  • To evaluate the existing evidence on whether lipid lowering interventions prevent coronary heart disease (CHD) events specifically in women.
  • To analyze the impact of cholesterol-lowering strategies on mortality and coronary atherosclerosis in female populations.

Main Methods:

  • Systematic review and meta-analysis of English-language literature.
  • Inclusion of studies on dietary and/or drug interventions for primary or secondary prevention of CHD events in women.
  • Calculation of relative risks for CHD and total mortality, with meta-analytic techniques for summary risks.

Main Results:

  • Primary prevention trials lack evidence that cholesterol lowering impacts total mortality in healthy women, though data are limited.
  • Limited evidence suggests that treating hypercholesterolemia in women with established coronary disease may reduce CHD mortality.
  • Angiographic regression of coronary atherosclerosis was assessed as a secondary outcome.

Conclusions:

  • Current evidence does not support cholesterol lowering for primary prevention of total mortality in healthy women.
  • Treatment of hypercholesterolemia may offer benefits for CHD mortality in women with existing coronary disease.
  • Future research should focus on non-drug interventions for hypercholesterolemia in high-risk women.
Abstract

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...